10:27 AM EDT, 03/12/2026 (MT Newswires) -- Abivax ( ABVX ) denied an earlier report in La Lettre stating that the company granted AstraZeneca ( AZN ) exclusive access to confidential information until March 23 with a view to formalizing an offer, Bloomberg reported Thursday, citing an emailed statement from the company's head of investor relations.

Abivax ( ABVX ) and AstraZeneca ( AZN ) didn't immediately reply to requests for comment from MT Newswires.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 111.70, Change: -0.61, Percent Change: -0.54